Skip to main content
. Author manuscript; available in PMC: 2019 Apr 24.
Published in final edited form as: JCSM Rapid Commun. 2019 Jan-Jun;2(1):e00075.

Figure 5.

Figure 5.

Carboplatin reduced tumor cell-induced loss of cortical bone.

(a) Representative microCT scans of the femur from Non-tumor + vehicle, MDA-MB-321 + vehicle, Non-tumor + carboplatin, and MDA-MB-231 + carboplatin groups. (b) Quantitation of Ct. BV/TV and Ct.Ar. (b) One-way ANOVA with Tukey’s post-hoc test for multiple comparisons, (n=7), *p<0.05, **p<0.01, ****p<0.0001 compared to Non-tumor + vehicle group. #p<0.05, ##p<0.01 compared to MDA-MB-231 + vehicle group. ‡p<.05 compared to Non-tumor + carboplatin group.